Alpha Tau Medical (NASDAQ: DRTS) CFO sells 2,127 shares after exercising options

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. Chief Financial Officer Raphi Levy reported an exercise-and-sale transaction in Ordinary Shares. Levy sold 2,127 shares in an open-market transaction at an average price of $13.0189 per share and reported direct ownership of 90,180 shares immediately afterward. The filing also shows a corresponding M-code transaction for 2,127 shares at $2.98 per share classified as a derivative exercise or conversion, indicating these shares were acquired through an option exercise before being sold.

Insider Trade Summary 10b5-1

Net Seller: 2,127 shares ($27,691)

Net Sell 2 txns

Insider Levy Raphi

Role Chief Financial Officer

Sold 2,127 shs ($28K)

Type	Security	Shares	Price	Value
Exercise	Ordinary Shares	2,127	$2.98	$6K
Sale	Ordinary Shares	2,127	$13.0189	$28K

Holdings After Transaction: Ordinary Shares — 92,307 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 2,127 shares Sale price: $13.0189 per share Post-transaction holdings: 90,180 shares +1 more

4 metrics

Shares sold 2,127 shares Open-market sale of Ordinary Shares

Sale price $13.0189 per share Average price for 2,127-share sale

Post-transaction holdings 90,180 shares Ordinary Shares held directly after sale

Exercise transaction amount 2,127 shares at $2.98 Derivative exercise or conversion

Key Terms

open-market sale, derivative exercise/conversion, Ordinary Shares, Form 4

4 terms

open-market sale financial

"Levy sold 2,127 shares in an open-market transaction at an average price"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

derivative exercise/conversion financial

"classified as a derivative exercise or conversion, indicating these shares were acquired"

Ordinary Shares financial

"reported an exercise-and-sale transaction in Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Form 4 regulatory

"as disclosed in a Form 4 insider trading report"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 11:46 AM Accepted by SEC EDGAR 07/02/2026 - 11:45 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levy Raphi

(Last) (First) (Middle)

C/O ALPHA TAU MEDICAL

PO BOX 45044

(Street)

JERUSALEM 9777605

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alpha Tau Medical Ltd. [ DRTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/01/2026	07/01/2026	M		2,127	A	$2.98	92,307	D
Ordinary Shares	07/01/2026	07/01/2026	S		2,127	D	$13.0189	90,180	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Raphi Levy	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Alpha Tau Medical (DRTS) report for Raphi Levy?

Alpha Tau Medical reported that CFO Raphi Levy sold 2,127 Ordinary Shares in an open-market transaction. The sale occurred at an average price of $13.0189 per share, as disclosed in a Form 4 insider trading report.

How many Alpha Tau Medical (DRTS) shares does Raphi Levy hold after the Form 4 transaction?

After the reported transactions, CFO Raphi Levy directly holds 90,180 Ordinary Shares of Alpha Tau Medical. This post-transaction balance reflects his remaining stake following the 2,127-share open-market sale disclosed in the filing.

At what prices did Raphi Levy’s Alpha Tau Medical (DRTS) transactions occur?

The Form 4 shows an open-market sale of 2,127 Ordinary Shares at $13.0189 per share. It also reports a related derivative exercise or conversion of 2,127 shares at a transaction price entry of $2.98 per share.

What do the S and M transaction codes mean in the Alpha Tau Medical (DRTS) Form 4?

In this Form 4, code S indicates a sale of 2,127 Ordinary Shares in an open-market or private transaction. Code M reflects a derivative exercise or conversion for 2,127 shares, showing shares acquired through an option-like instrument.

Is Raphi Levy’s Alpha Tau Medical (DRTS) transaction classified as direct or indirect ownership?

The Form 4 classifies Raphi Levy’s reported holdings and transactions as direct ownership. The ownership code is D, and there is no nature-of-ownership footnote indicating that the shares are held through a separate entity or trust.